169324 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Quantitative determination of biomarkers in the erythrocyte membrane
#902METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUS
#903Composition and method for measuring thallium influx and efflux
#904METHOD FOR PRETREATING BIOLOGICAL SAMPLE CONTAINING PROTEIN
#905DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#906METHOD OF PROGNOSIS
#907Method for diagnosis of pulmonary involvement in systemic sclerosis
#908Methods for screening voltage-gated proteins
#909Compositions and methods related to protein displacement therapy for myotonic distrophy
#910USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#911Process for making modulators of cystic fibrosis transmembrane conductance regulator
#912Use of integrin beta subunits in the diagnosis of venous thromboembolism
#913High throughput screen
#914MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#915INHIBITING INTERACTION BETWEEN HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED HELICES
#916Detection of platelet-derived shed CD31
#917THERAPEUTIC USES OF HUMANIZED ANTIBODIES AGAINST ALPHA-4 INTEGRIN
#918STABILIZED LOW AFFINITY CONFORMATION OF INTEGRINS FOR DRUG DISCOVERY
#919Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena
#920Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#921Identification of olfactory receptors sensitive to different odorants
#922Method for studying transport of an agent across a bilayer membrane in bioanalytical sensor applications
#923Biomarkers of oxidative stress
#924Protein chips, preparation and use thereof
#925METHODS FOR ASSESSING RISK FOR CANCER USING BIOMARKERS
#926Oligopeptidic compounds and uses thereof
#927METHOD FOR DETERMINING THE IMMUNE STATUS OF A SUBJECT
#928Methods of enhancing translocation of charged analytes through transmembrane protein pores
#929Transcriptional repression leading to parkinson's disease
#930MCT protein inhibitor-related prognostic and therapeutic methods
#931Determination of sFlt-1:angiogenic factor complex
#932Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
#933Simultaneous Assay of Target and Target-Drug Binding
#934Transmembrane protein as biosensors
#935Synthetic mammalian neuromuscular junction and method of screening for a candidate drug thereon
#936METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE
#937Modulators of ATP-binding cassette transporters
#938ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES
#939Detection of human somatic cell reprogramming
#940SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF
#941GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
#942SYSTEMS AND METHODS FOR ASSESSMENT OF BIOSIMILARITY
#943Sensors and assays for ubiquitin or ubiquitin-like proteins
#944Nanopore device for drug-like molecule screening or lead optimization to a targeted protein
#945DETECTION, ISOLATION AND ANALYSIS OF RARE CELLS IN BIOLOGICAL FLUIDS
#946Chaperone interaction assays and uses thereof
#947MSP nanopores and related methods
#948Remedy for diabetes
#949Msp nanopores and related methods
#950METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME
#951Soluble mediator
#952porins and toxins and related methods
#953METHODS FOR SCREENING A BRCA1 LOSS-OF-FUNCTION IN A SUBJECT SUFFERING FROM A CANCER
#954SECRETED PROTEINS AND USES THEREOF
#955Systems, methods, and workflows for optogenetics analysis
#956Method for treatment of mesothelioma
#957CANINE/FELINE CD20 BINDING EPITOPE AND COMPOSITIONS FOR BINDING THERETO
#958System and method for execution of a secured environment initialization instruction
#959Therapeutic and Diagnostic Methods for Manipulating Phagocytosis Through Calreticulin and Low Density Lipoprotein-Related Receptor
#960Msp nanopores and related methods
#961Methods for Identifying and Compounds Useful for Increasing the Functional Activity and Cell Surface Expression of CF-Associated Mutant Cystic Fibrosis Transmembrance Conductance Regulator
#962PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#963Method for monitoring, diagnosis and/or prognosis of hypoxia related disorders using NFAT5
#964Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#965CLONED GLUCAGON-LIKE PEPTIDE-2 RECEPTORS
#966Diagnosis and treatment of kidney stones, methods and compositions therefor
#967Agents and methods for treating ischemic and other diseases
#968Methods for treating neural cell swelling
#969Method of identifying abnormal cells by expression levels of ETFB
#970Modular sensor architecture for cell based biosensors
#971Mutations associated with cystic fibrosis
#972Microarray device for screening or locating HSP90 inhibitors or inhibitors of further disease-relevant target structures
#973Anti-Axl antibodies and uses thereof
#974SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4)
#975METHODS FOR USE WITH BAFF ANTAGONISTS
#976RNA-YY1 interactions
#977Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#978DIAGNOSTIC TEST AND TREATMENT FOR A NEUROLOGICAL DISORDER
#979Methods for determining binding capability of target ligands with G protein-coupled receptors using translocation through nanochannels
#980METHOD FOR SCREENING OF AGENT FOR TREATING OR PREVENTING OBESITY
#981Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dysfunction
#982Compositions and methods for treatment
#983Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditions
#984Monoclonal antibodies against PCBP-1 antigens, and uses therefor
#985Lipoparticles comprising proteins, methods of making, and using the same
#986Annexin V variant and its preparation and application
#987Induction of the mitochondrial permeability transition
#988METHODS FOR DETERMINING SODIUM-PROTON-EXCHANGER LIGAND EFFICIENCY
#989Methods and agents for modulating protocadherin-18 activity
#990MODULATORS OF SLC22A7
#991Reducing soluble urokinase receptor in the circulation
#992Treatment of pain
#993METHOD OF TREATING RHEUMATOID ARTHRITIS
#994Ribosome structure and protein synthesis inhibitors
#995Biologically active complex and its preparation
#996Antibody and binding fragment recognizing CACNA2D1 and use thereof
#997METHOD OF TREATING AUTOIMMUNE INFLAMMATORY DISORDERS USING IL-23R LOSS-OF-FUNCTION MUTANTS
#998Neuregulin variants and methods of screening and using thereof
#999Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
#1000Biomarkers for non-hodgkin lymphomas and uses thereof
#1001Method for screening for compound capable of enhancing or inhibiting OATP1B1 transport activity, and method for determining expression level of OATP1B1
#1002Surrogates of post-translationally modified proteins and uses thereof
#1003BIOLOGICAL MARKER FOR INFLAMMATION
#1004T1R taste receptors and genes encoding same
#1005Ex vivo methods to identify circulating drug metabolites with drug interaction potential
#1006Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac Glycoside
#1007Method for Analyzing Apoptosis Inducing Factor-2
#1008Modulators of cystic fibrosis transmembrane conductance regulator
#1009Prodrugs of Modulators of ABC Transporters
#1010Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
#1011METHOD FOR DETECTION OF BASIC PEPTIDE AND REAGENT FOR DETECTION OF BASIC PEPTIDE
#1012Cell line, system and method for optical-based screening of ion-channel modulators
#1013Biomarkers for theranostics
#1014Mutant channelrhodopsin 2
#1015Bioassay method for detecting physiologically active substance
#1016Methods of identifying molecules that provide or enhance sweet taste
#1017Method for screening drugs for suppressing inflammasome activity
#1018Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
#1019Treatment of penetrative injury to the brain
#1020Function homology screening
#1021Compositions and Methods for the Diagnosis and Treatment of Primary Insulin-Like Growth Factor Deficiency (PIGFD) and Idiopathic Short Stature (ISS)
#1022Method for the diagnosis and/or prognosis of granulocyte-related inflammatory states
#1023TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
#1024Methods for measuring analyte transport across barriers using x-ray fluorescence
#1025TDF-related compounds and analogs thereof, analogs and bioactive fragments
#1026Software Integrated Flow Cytometric Assay For Quantification Of The Human Polymorphonuclear Leukocyte FCgammaRI Receptor (CD64)
#1027USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES
#1028METHODS AND COMPOSITIONS FOR TREATMENT OF TOX-3 AND TFF-1 MEDIATED CANCER PATHOGENESIS
#1029Modulation of NR2F6 and methods and uses thereof
#1030Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
#1031Optogenetic probes for measuring membrane potential
#1032Methods of identifying insect-TRPA1 modulators
#1033METHOD FOR THE PROGNOSIS OF THE PROGRESSION OF CANCER
#1034METHOD AND KIT FOR THE DIAGNOSIS AND/OR PROGNOSIS OF TOLERANCE IN LIVER TRANSPLANTATION
#1035System and method for execution of a secured environment initialization instruction
#1036SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSIS
#1037Method for detecting invasive microvesicles derived from tumor cells
#1038DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody
#1039Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
#1040Monoclonal antibodies against PCBP-1 antigens, and uses therefor
#1041Light-activated cation channel and uses thereof
#1042Material for screening for compound acting on ion channel and use thereof
#1043METHOD OF EVALUATING IMMUNOSUPPRESSION
#1044ARNT ISOFORM 3 AS A PREDICTOR OF AMINOFLAVONE RESPONSIVENESS IN CANCER CELLS
#1045Methods for the Regulation of Cellular Metabolism Through the Modulation of SIRT3 Activity
#1046Modulators of ATP-binding cassette transporters
#1047IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSIS
#1048Formation of bilayers of amphipathic molecules
#1049High throughput screening of ion channels
#1050Humanized and chimeric monoclonal antibodies to CD47
#1051Methods and kits for modulating tumor invasiveness and metastatic potential
#1052PAXILLIN AS A THERAPEUTIC OR DIAGNOSTIC MARKER FOR CANCER
#1053Prediction and recognition of acute kidney injury after surgery
#1054Compositions and methods for increasing bone mineralization
#1055Ubiquitination assay
#1056Methods and devices for diagnosing cardiac disorders
#1057MULTIPLE MYELOMA PROGNOSIS AND TREATMENT
#1058Antibody for the diagnosis and/or prognosis of cancer
#1059Assay for detection of transient intracellular Ca
#1060Cardiovascular Risk Event Prediction and Uses Thereof
#1061Process for making modulators of cystic fibrosis transmembrane conductance regulator
#1062INDUCIBLE EXPRESSION OF SGLT5, METHODS AND KITS USING THE SAME
#1063Method for producing cAMP using chimeric olfactory receptor
#1064Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin
#1065Prognostic method
#1066CATION CHANNEL ACTIVITY
#1067LABEL-FREE METHODS RELATED TO hERG POTASSIUM ION CHANNELS
#1068METHOD FOR ASSESSMENT OF POTENTIAL FOR DEVELOPMENT OF DRAVET SYNDROME AND USE THEREOF
#1069Antibody that specifically binds to an epitope in the tureet region of a human Kir channel
#1070Modulators of ATP-binding cassette transporters
#1071Monitoring and manipulating cellular transmembrane potentials using nanostructures
#1072METHODS OF STRATIFYING ADOLESCENT IDIOPATHIC SCOLIOSIS, ISOLATED NUCLEIC ACID MOLECULES FOR USE IN SAME AND KITS USING SAME
#1073Heteroaryl derivatives as CFTR modulators
#1074Use of biological photoreceptors as directly light-activated ion channels
#1075MANIPULATION OF CALCIUM CHANNELS TO REGULATE AFTER-DEPOLARIZATION EVENTS IN CARDIAC MYOCYTES
#1076METHODS OF USING PRDM1 GENETIC VARIANTS TO PROGNOSE, DIAGNOSE AND TREAT INFLAMMATORY BOWEL DISEASE
#1077Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate
#1078Arrays Of Biological Membranes And Methods And Use Thereof
#1079Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1080Method for evaluating cell aging by expression level of cofilin
#1081Prevention and treatment of osteoarthritis
#1082MOLECULES RELATED hERG ION CHANNELS AND THE USE THEREOF
#1083Use of α1G subunit of T-type calcium channel as diagnostic marker for pregnancy in cattle
#1084MOLECULAR MARKER FOR EVALUATING PATHOLOGICAL CONDITIONS AND TREATMENT OF MUSCULAR DYSTROPHY
#1085Modulation of synaptic maintenance
#1086Methods of inhibiting staphylobactin-mediated iron uptake in
#1087Method and compositions for treating cancer and related methods
#1088COMPOUND CAPABLE OF BINDING TO NATURALLY OCCURRING DENATURED PROTEIN, AND METHOD FOR SCREENING FOR THE COMPOUND
#1089METHODS AND COMPOSITIONS FOR CANCER TREATMENT RELATING TO BRCA1 BRCT DOMAIN RECOGNITION OF PHOSPHORYLATED BACH1
#1090Endoglin antibodies
#1091Sodium channel protein type III α-subunit splice variant
#1092METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#1093STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#1094T1R taste receptors and genes encoding same
#1095Methods of using voltage-gated Hv1 proton channels to detect changes in intracellular pH
#1096Screening method for cell aging
#1097METHODS AND COMPOSITIONS FOR MODULATING CALCIUM CHANNELS
#1098ASSAY FOR ORAI CALCIUM CHANNEL REGULATORS
#1099RECEPTORS OF RSPO2 AND RSPO3
#1100Use of K2P potassium channel activators as antalgics
#1101Treatment and prevention of dengue virus infections
#1102COMPOUNDS FOR ALLEVIATING PAIN AND STRESS IN FETUS AND NEWBORN
#1103METHOD OF PROGNOSIS
#1104PODOCYTE SPECIFIC ASSAYS AND USES THEREOF
#1105OBJECTIVE, QUANTITATIVE METHOD TO PREDICT HISTOLOGICAL SUBTYPE IN NON-SMALL CELL LUNG CANCER
#1106Method for detection of basic peptide and reagent for detection of basic peptide
#1107MCAM as a biomarker for fluid homeostasis
#1108METHODS FOR TREATING NEURAL CELL SWELLING
#1109Compositions and methods for treatment of eye disorders
#1110FLUORESCENCE POLARIZATION hERG ASSAY
#1111Blood Biomarkers for Bone Fracture and Cartilage Injury
#1112METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#1113Islet1 (Isl1) and hearing loss
#1114BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#1115System and method for execution of a secured environment initialization instruction
#1116COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CARCINOMA
#1117METHOD FOR MEASUREMENT OF FLUORESCENCE INTENSITY OF VOLTAGE-SENSITIVE FLUORESCENT DYE
#1118Modulators of cystic fibrosis transmembrane conductance regulator
#1119COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION
#1120FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#1121METHODS AND COMPOSITIONS FOR IDENTIFYING MODULATORS OF ANTI-TETHERIN ACTIVITY TO INHIBIT PROPAGATION OF VIRUSES
#1122Modulation of synaptic maintenance
#1123Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
#1124MULTIPLE MYELOMA PROGNOSIS AND TREATMENT
#1125Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#1126Detection of cells expressing T1R2 taste receptor
#1127T1R taste receptors and genes encoding same
#1128T-Bet Compositions and Methods of Use Thereof
#1129Method for optical measuring variations of cell membrane conductance
#1130Molecular indicia of cellular constituents and resolving the same by super-resolution technologies in single cells
#1131Cystic fibrosis transmembrane conductance regulator gene mutations
#1132Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation
#1133Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
#1134Prognosis diagnosis method and prognosis diagnosis kit for sepsis or multiple organ failure
#1135AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT VOLTAGE-GATED POTASSIUM CHANNEL ACTIVITY
#1136DEVICES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF WOUNDS USING BIOMARKERS
#1137Molecularly imprinted polymer for detecting the pentraxin, and method for preparing same
#1138Transcriptional repression leading to Parkinson's disease
#1139PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#1140Method for detecting invasive microvesicles derived from tumor cells
#1141Granules with reduced dust potential comprising an antifoam agent
#1142Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1143USE OF CYTOPLASMIC C-MYC FOR REGULATING IMMUNE RESPONSES
#1144PEPTIDE-BASED REGULATION OF GAP JUNCTIONS
#1145Use of Vgll3 activity modulator for the modulation of adipogenesis
#1146Agents and methods for tissue repair and regeneration
#1147Compositions and methods for the treatment of disease associated with TRP-P8 expression
#1148Mass spectrometric methods and products
#1149IN VITRO METHODS FOR DETERMINING AN INTRACELLULAR FREE MAGNESIUM DEFICIENCY OF INDIVIDUALS BY DETERMINING THE EXPRESSION RATE OF A CELLULAR MG TRANSPORTER GENE
#1150Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FCγRI receptor (CD64)
#1151METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE
#1152Method for transporting potassium ions from front side to back side of lipid bilayer membrane
#1153Modulators of cystic fibrosis transmembrane conductance regulator
#1154Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes
#1155Non-functional P2Xreceptor
#1156Drug target that promotes secretory granule-granule fusion
#1157Use of megalin in urine as marker for detecting renal disorder
#1158MSP nanopores and related methods
#1159SYNAPTIC VESICLE CYCLING ASSAYS AND SYSTEMS
#1160METHODS OF DIAGNOSING CERVICAL CANCER
#1161p16 MEDIATED REGULATION OF NMDA RECEPTORS
#1162METHOD FOR THE SELECTIVE CONCENTRATION OF A SPECIFIC LOW ABUNDANCE BIOMOLECULE
#1163Mutated voltage-gated sodium channel Naalpha subunit for identification of modulators
#1164MIF antagonists
#1165USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
#1166Activation and monitoring of cellular transmembrane potentials
#1167Method for screening a salty taste modulating substance
#1168Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same
#1169COMPOSITIONS AND METHODS FOR MODULATING THE ACID-SENSING ION CHANNEL (ASIC)
#1170DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#1171METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING alpha1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS
#1172Method for identifying an antagonist of guanine nucleotide releasing factor 1
#1173Materials and methods for treatment of cancer and identification of anti-cancer compounds
#1174Methods, products and treatments for diabetes
#1175Inhibitors of BCL-2
#1176Improving vascular function with an inactivating mutant of a TRPC channel protein
#1177CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
#1178Method for Evaluating Immunosuppression
#1179METHODS OF ENHANCING TRANSLOCATION OF CHARGED ANALYTES THROUGH TRANSMEMBRANE PROTEIN PORES
#1180COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
#1181Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1
#1182Detection and treatment of pancreatic, ovarian and other cancers
#1183INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#1184Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#1185High throughput assay for discovering new inhibitors of the GIRK1/4 channel
#1186Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
#1187Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders
#1188METHOD FOR USING DIVISION ARRESTED CELLS IN SCREENING ASSAYS
#1189Use of precursors of tachykinins and/or their fragments in medical diagnostic
#1190Ferroportin antibodies and methods of use
#1191MODIFIED PYR/PYL RECEPTORS ACTIVATED BY ORTHOGONAL LIGANDS
#1192BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
#1193Screening assay for insecticides
#1194DIFFERENTIATING BETWEEN FIBROSIS AND CIRRHOSIS
#1195Methods for determining sodium-proton-exchanger ligand efficiency
#1196BLOOD-BRAIN BARRIER TARGETING ANTIBODIES
#1197Methods for diagnosing heart failure and other cardiac diseases
#1198Detection of human somatic cell reprogramming
#1199Small molecule inhibitors of MUC1 and methods of identifying the same
#1200Agents and methods for treating ischemic and other diseases